Discover
REVB
Revelation Biosciences, Inc.
0.93
2 x 0.63
2 x 1.25
bid
ask
-
0.03
3.02%
2 @ 06:27 PM
0.98 +0.05 (5.87%)
| Ytd | -70.92% | |
| 1y | -85.09% |
0.93
day range
0.98
0.91
52 week range
6.24
| Open | 0.98 | Prev Close | 0.96 | Low | 0.93 | High | 0.98 | Mkt Cap | 3.71M |
| Vol | 15.80K | Avg Vol | 37.78K | EPS | 27.03 | P/E | 0.03 | Forward P/E | -0.13 |
| Beta | -0.14 | Short Ratio | 0.11 | Inst. Own | 8.90% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-05 | 50-d Avg | 1.05 | 200-d Avg | 1.63 | 1yr Est | 12.75 |
Earning
| Date | For | Estimate | Reported | Surprise | surprise % |
|---|---|---|---|---|---|
| 2024-11-08 | 2024-09 | -2.84 | -0.84 | 2 | 70.42% |
| 2024-08-09 | 2024-06 | -1.81 | -1.54 | 0.27 | 14.92% |
| 2024-08-09 | 2024-06 | -1.81 | N/A | N/A | N/A |
| 2024-05-10 | 2024-03 | -5.39 | -2.46 | 2.93 | 54.36% |
| 2024-05-10 | 2024-03 | -5.39 | N/A | N/A | N/A |
| 2024-03-22 | 2023-12 | -10.94 | -8.33 | 2.61 | 23.86% |
Upgrade / Downgrade
| Date | Firm | Action | From | To |
|---|
Profile
Revelation Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of immune system therapeutics and diagnostics. It engages in developing therapeutic product candidates, including GEM-SSI, a potential therapy for the prevention and treatment of surgical sit infection; GEM-AKI, a potential therapy for the prevention and treatment of acute kidney injury; and GEM-CKD, a potential therapy for the prevention and treatment of chronic kidney disease. The company was founded in 2020 and is based in San Diego, California.
Insider Holder
| Date | Name | Relation | Quantity | Description |
|---|---|---|---|---|
| 2023-12-07 | TIDMARSH GEORGE F | Director | 42.10K | Sale |
Institution Ownership
| Report Date | Organization | Position | Value | Percentage |
|---|---|---|---|---|
| 2024-09-29 | Sabby Management, LLC | 42.23K | 12.77K | 0.51% |
| 2024-09-29 | UBS Group AG | 40.95K | 12.38K | 0.49% |
| 2024-09-29 | Susquehanna International Group, LLP | 13.26K | 4.01K | 0.16% |
| 2024-09-29 | Tower Research Capital LLC (TRC) | 2.54K | 767.00 | 0.03% |
| 2024-09-29 | Pom Investment Strategies, LLC | 1.00 | 0.00 | 0.00% |
| 2024-09-29 | Bank of America Corporation | 29.00 | 8.00 | 0.00% |
Fund Ownership
| Report Date | Organization | Position | Value | Percentage |
|---|---|---|---|---|
| 2024-10-30 | Fidelity Extended Market Index Fund | 8.02K | 2.42K | 0.10% |
| 2024-10-30 | Fidelity Series Total Market Index Fund | 2.94K | 889.00 | 0.04% |
| 2024-09-29 | Vanguard Extended Market Index Fund | 201.00 | 60.00 | 0.00% |
Split
| Split | Date |
|---|---|
| 1 : 4 | 2026-01-28 |
| 1 : 3 | 2025-07-07 |
| 1 : 16 | 2025-01-28 |
| 1 : 30 | 2024-01-25 |
| 1 : 35 | 2023-02-01 |